EurekAlert! -
6 Apr 2018 06:00
(NIH/National Institute of Allergy and Infectious Diseases) Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS) p...
Share this Article